On March 21, 2024, GSK plc transferred 27,800,000 ordinary shares to JPMorgan Chase, receiving $41.93 per ADR for the issuance of 13,900,000 ADRs to the GlaxoSmithKline Trust. Following this, GSK's issued share capital includes 4,314,051,101 shares, with 4,144,879,946 voting rights available.